Hexoprenaline

Hexoprenaline

Systematic (IUPAC) name
(±)-4,4'-{hexane-1,6-diylbis[imino(1-hydroxyethane-2,1-diyl)]}dibenzene-1,2-diol
Clinical data
AHFS/Drugs.com	International Drug Names
Identifiers
CAS Number	3215-70-1 Y
ATC code	R03AC06 (WHO) R03CC05
PubChem	CID: 3609
DrugBank	DB08957 N
ChemSpider	3483 N
UNII	G9L6B3W684 Y
Synonyms	4-[2-[6-([2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]amino)hexylamino]-1-hydroxyethyl]benzene-1,2-diol
Chemical data
Formula	C22H32N2O6
Molecular mass	420.499 g/mol
SMILES C1=CC(=C(C=C1C(CNCCCCCCNCC(C2=CC(=C(C=C2)O)O)O)O)O)O
InChI InChI=1S/C22H32N2O6/c25-17-7-5-15(11-19(17)27)21(29)13-23-9-3-1-2-4-10-24-14-22(30)16-6-8-18(26)20(28)12-16/h5-8,11-12,21-30H,1-4,9-10,13-14H2 N Key:OXLZNBCNGJWPRV-UHFFFAOYSA-N N
NY (what is this?)  (verify)

Hexoprenaline (INN) is a β2-adrenergic receptor agonist used in the treatment of asthma.

Hexoprenaline is also used as a tocolytic agent (i.e., It can suppress labor). Contraindications to its use as a tocolytic agent are cardiovascular disease, surgical shock, tachycardia, diabetes mellitus.